| Literature DB >> 34072135 |
Ali Es-Haghi1, Mohammad Ehsan Taghavizadeh Yazdi2, Mohammad Sharifalhoseini3, Mohsen Baghani1, Ehsan Yousefi1, Abbas Rahdar4, Francesco Baino5.
Abstract
In this study, the biosynthesis of zinc oxide nanoparticles using Aspergillus niger (A/ZnO-NPs) is described. These particles have been characterized by UV-Vis spectrum analysis, X-ray powder diffraction, field emission scanning electron microscopy, and transmission electron microscopy. To use this biosynthesized nanoparticle as an antiproliferative and antimicrobial agent, the IC50 value against the breast cancer cell line and inhibition zone against Escherichia coli were used to optimize the effect of two processing factors including dose of filtrate fungi cell and temperature. The biosynthesized A/ZnO-NPs had an absorbance band at 320 nm and spherical shapes. The mean particles size was 35 nm. RSM (response surface methodology) was utilized to investigate the outcome responses. The Model F-value of 12.21 and 7.29 implies that the model was significant for both responses. The contour plot against inhibition zone for temperature and dose showed that if the dose increases from 3.8 to 17.2 µg/mL, the inhibition zone increases up to 35 mm. As an alternative to chemical and/or physical methods, biosynthesizing zinc oxide NPs through fungi extracts can serve as a more facile and eco-friendly strategy. Additionally, for optimization of the processes, the outcome responses in the biomedical available test can be used in the synthesis of ZnO-NPs that are utilized for large-scale production in various medical applications.Entities:
Keywords: anticancer; antimicrobial; nanomaterials; optimization; response surface methodology; zinc oxide
Year: 2021 PMID: 34072135 PMCID: PMC8167739 DOI: 10.3390/biomimetics6020034
Source DB: PubMed Journal: Biomimetics (Basel) ISSN: 2313-7673
Figure 1A tentative mechanism for the formation of ZnO-NPs by A. niger.
Figure 2UV–Vis spectroscopy of the biosynthesized A/ZnO-NPs.
Figure 3PXRD pattern of green synthesized A/ZnO-NPs.
Figure 4TEM image of the biosynthesized A/ZnO-NPs and its histogram of particle diameter.
Figure 5FESEM image of the biosynthesized A/ZnO-NPs.
Central composite design (CCD) for the two variables (temperature and dose of biosynthesized NPs) and two experimental responses (IC50 and inhibition zone).
| Factor 1 | Factor 2 | Response 1 | Response 2 | |
|---|---|---|---|---|
| Std | A: Temperature | B:Dose | IC50 | Inhibition zone (mm) |
| 1 | 36.0 | 3.8 | 17 | 20 |
| 2 | 89.0 | 3.8 | 15 | 17 |
| 3 | 36.0 | 17.2 | 5 | 40 |
| 4 | 89.0 | 17.2 | 5 | 40 |
| 5 | 25.0 | 10.5 | 120 | 2 |
| 6 | 100.0 | 10.5 | 50 | 2 |
| 7 | 63 | 1.0 | 50 | 2 |
| 8 | 63 | 20.0 | 2 | 46 |
| 9 | 63 | 10.5 | 150 | 2 |
| 10 | 63 | 10.5 | 150 | 2 |
| 11 | 63 | 10.5 | 150 | 2 |
| 12 | 63 | 10.5 | 150 | 2 |
| 13 | 63 | 10.5 | 150 | 2 |
ANOVA of the response surface quadratic model for IC50.
| Source | Sum of Squares | df | Mean Square | F-Value | |
|---|---|---|---|---|---|
|
| 47,886.85 | 5 | 9577.37 | 12.21 | 0.0024 |
|
| 1275.00 | 1 | 1275.00 | 1.63 | 0.2430 |
|
| 1009.85 | 1 | 1009.85 | 1.29 | 0.2938 |
|
| 1.00 | 1 | 1.00 | 0.0013 | 0.9725 |
|
| 13,315.22 | 1 | 13,315.22 | 16.98 | 0.0045 |
|
| 37,325.65 | 1 | 37,325.65 | 47.60 | 0.0002 |
|
| 5489.15 | 7 | 784.16 |
Figure 6The predicted response values versus the actual response values for IC50.
Final equation in terms of actual factors.
| IC50 | = |
|---|---|
| −222.86128 | |
| +7.27221 | Temperature |
| +32.24067 | Dose |
| +0.002807 | Temperature × Dose |
| −0.062222 | (Temperature)² |
| −1.62327 | (Dose)² |
Figure 7(a) The contour plot and (b) 3D surface plot for the dose and temperature for IC50 response.
Figure 8(a) The contour plot and (b) 3D surface plot for dose and temperature for inhibition zone.
ANOVA for response surface quadratic model for the inhibition zone.
| Source | Sum of Squares | df | Mean Square | F-Value | |
|---|---|---|---|---|---|
|
| 2996.86 | 5 | 599.37 | 7.29 | 0.0107 |
|
| 1.13 | 1 | 1.13 | 0.0137 | 0.9102 |
|
| 1384.05 | 1 | 1384.05 | 16.84 | 0.0046 |
|
| 2.25 | 1 | 2.25 | 0.0274 | 0.8733 |
|
| 114.81 | 1 | 114.81 | 1.40 | 0.2759 |
|
| 1578.29 | 1 | 1578.29 | 19.20 | 0.0032 |
|
| 575.45 | 7 | 82.21 |
Final equation in terms of actual factors.
| Inhibition Zone | = |
|---|---|
| +44.45795 | |
| −0.780575 | Temperature |
| −5.31481 | Dose |
| +0.004211 | Temperature × Dose |
| +0.005778 | (Temperature)² |
| +0.333795 | (Dose)² |